ASPI · ASP Isotopes Inc.
Market Cap
$643.90M
Shares
153.31M
ASPI metrics
64 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$4.20
Market cap
$643.90M
Price action
19 metricsPrice change (1W)
+8.2%
Price change (30D)
-2.1%
Price change (3M)
-37.4%
Price change (6M)
-24.3%
Price change (YTD)
-21.5%
Price change (1Y)
-47.2%
Trailing year
Price change (5Y)
—
52-week high
$14.05
52-week low
$3.54
Change from 52-week high
-70.1%
Change from 52-week low
+18.6%
Annualized volatility
105.9%
Beta
3.7
RSI (14D)
51.8
Price vs SMA 50
-4.2%
Price vs SMA 200
-24.2%
Avg volume (3M)
4.01M
Relative volume
1.0
Average dollar volume
$20.26M
Company
3 metricsSector
Basic Materials
Industry
Specialty Chemicals
Shares outstanding
153.31M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
14.5×
reciprocal yield 6.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
20.9×
reciprocal yield 4.8%
P / book
2.4
reciprocal yield 41.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-18.2%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
32.1×
reciprocal yield 3.1%
EV / revenue historical average (5Y)
32.1×
reciprocal yield 3.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-04-13
Profitability
9 metricsGross margin
18.3%
Operating margin
-321.1%
Trailing 12 months
Net margin
-380.3%
Gross profit (TTM)
$5.65M
Operating profit (TTM)
−$99.07M
Net income (TTM)
−$117.34M
Trailing 12 months
Diluted EPS (TTM)
$-1.29
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+327.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$30.85M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+68.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-44.3%
Return on assets
-20.5%
Debt / equity
0.2
Current ratio
3.9
EBITDA (TTM)
−$93.58M
Free cash flow (TTM)
—
Quick ratio
3.9
Interest coverage
-25.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$195.13M
Latest balance sheet
Cash & equivalents
$219.60M
Total assets
$572.05M
Total debt
$59.77M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$67.80M
Capital expenditures (TTM)
—
R&D (TTM)
$22.04M
SG&A (TTM)
—
Stock compensation (TTM)
$18.66M
R&D / revenue
71.4%
Stock compensation / revenue
60.5%
Ownership (13F)
3 metrics13F filers
189
13F filer change QoQ
+9
Institutional ownership
48.8%
Short interest
3 metricsShort interest
17.5%
Latest settlement · 8.7 days to cover
Days to cover
8.7d
Short-squeeze score
67 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1921865
CUSIP
00218A105
13F (30d)
124 filings
124 filers
Visit website
Investor relations